Raymond James Trust’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $211K | Buy |
+1,072
| New | +$211K | ﹤0.01% | 1227 |
|
|
2024
Q2 | – | Sell |
-1,001
| Closed | -$271K | – | 1267 |
|
|
2024
Q1 | $271K | Sell |
1,001
-113
| -10% | -$30.6K | 0.01% | 1031 |
|
|
2023
Q4 | $263K | Buy |
1,114
+17
| +2% | +$4.02K | 0.01% | 995 |
|
|
2023
Q3 | $215K | Sell |
1,097
-20
| -2% | -$3.92K | 0.01% | 1046 |
|
|
2023
Q2 | $235K | Buy |
1,117
+51
| +5% | +$10.7K | 0.01% | 1027 |
|
|
2023
Q1 | $216K | Sell |
1,066
-23
| -2% | -$4.66K | 0.01% | 1032 |
|
|
2022
Q4 | $237K | Sell |
1,089
-138
| -11% | -$30K | 0.01% | 964 |
|
|
2022
Q3 | $241K | Sell |
1,227
-255
| -17% | -$50.1K | 0.01% | 896 |
|
|
2022
Q2 | $318K | Sell |
1,482
-43
| -3% | -$9.23K | 0.01% | 778 |
|
|
2022
Q1 | $433K | Buy |
1,525
+384
| +34% | +$109K | 0.01% | 695 |
|
|
2021
Q4 | $430K | Buy |
1,141
+376
| +49% | +$142K | 0.01% | 716 |
|
|
2021
Q3 | $315K | Sell |
765
-58
| -7% | -$23.9K | 0.01% | 831 |
|
|
2021
Q2 | $304K | Sell |
823
-344
| -29% | -$127K | 0.01% | 850 |
|
|
2021
Q1 | $338K | Buy |
1,167
+108
| +10% | +$31.3K | 0.01% | 772 |
|
|
2020
Q4 | $265K | Buy |
1,059
+54
| +5% | +$13.5K | 0.01% | 825 |
|
|
2020
Q3 | $228K | Sell |
1,005
-383
| -28% | -$86.9K | 0.01% | 824 |
|
|
2020
Q2 | $242K | Buy |
+1,388
| New | +$242K | 0.01% | 758 |
|